The SLC35C1 gene glycosylation disorder, also known as Congenital Disorder of Glycosylation Type 2C (CDG-IIc) or Leukocyte Adhesion Deficiency Type II, is a rare genetic condition that affects the body's ability to glycosylate proteins and lipids, which are crucial for various cellular functions. This disorder is caused by mutations in the SLC35C1 gene, which encodes a GDP-fucose transporter responsible for the transport of GDP-fucose into the Golgi apparatus, where it is utilized for fucosylation of glycoconjugates.
Individuals with this condition often present with a range of symptoms, including severe mental and growth retardation, abnormal fat distribution, seizures, and susceptibility to infections due to impaired leukocyte adhesion. Given the complexity and rarity of this disorder, genetic testing is vital for accurate diagnosis and management.
In the United Arab Emirates, DNA Labs UAE offers a genetic test specifically targeting the SLC35C1 gene to identify mutations associated with the glycosylation disorder type 2C. The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques to detect the presence of mutations in the SLC35C1 gene.
This genetic test is crucial for families with a history of the disorder, individuals showing symptoms, or those needing a definitive diagnosis for clinical management and genetic counseling. Early diagnosis through genetic testing like the one offered at DNA Labs UAE can lead to better management of symptoms and improved quality of life for affected individuals.
The ALG6 Gene Glycosylation Disorder Type 1C Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the ALG6 gene. These mutations are responsible for a type of Congenital Disorders of Glycosylation (CDG), specifically Type 1C, a rare genetic condition. CDGs are a group of inherited metabolic disorders that affect the glycosylation process, where sugars are attached to proteins and lipids, impacting multiple systems in the body including the nervous system, immune system, and gastrointestinal system.
This test, priced at 4400 AED, involves analyzing the patient's DNA to detect any abnormalities in the ALG6 gene that may lead to the disorder. Early detection through this genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, providing essential information for the diagnosis, treatment planning, and family genetic counseling of ALG6-CDG Type 1C.
The DPM1 Gene Glycosylation Disorder Type 1E Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the DPM1 gene, which are linked to Congenital Disorders of Glycosylation Type 1E (CDG-1E). These disorders are a group of rare genetic conditions that affect the normal process of glycosylation, the addition of sugars to proteins, which is crucial for proper protein function and cellular operations.
CDG-1E is characterized by a wide range of symptoms, including developmental delay, neurological issues, and abnormalities in organ function, stemming from the body's inability to properly attach sugar molecules to proteins. Early and accurate diagnosis through genetic testing is essential for managing symptoms and improving the quality of life for affected individuals.
The test at DNA Labs UAE involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific mutations in the DPM1 gene that are indicative of CDG-1E. The cost for this comprehensive genetic test is 4400 AED. Given the complexity and rarity of the condition, having access to this test represents a critical step towards personalized care and management for patients with suspected CDG-1E, offering families hope and direction in navigating this challenging condition.
The DPAGT1 gene glycosylation disorder type 1J genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DPAGT1 gene. These mutations can lead to a rare condition known as Congenital Disorder of Glycosylation Type 1j (CDG-1j), which affects the normal process of glycosylation, an essential biological mechanism where sugar molecules are attached to proteins and lipids, impacting their stability and function. This disorder can present with a wide range of symptoms, including developmental delay, neurological issues, and problems with the digestive system, among others.
Given the complexity of CDG-1j and the importance of early diagnosis for managing the condition, the test provided by DNA Labs UAE is crucial for families with a history of the disorder or presenting symptoms. At a cost of 4400 AED, the test is conducted using advanced genetic sequencing techniques to ensure accuracy and reliability in detecting any mutations in the DPAGT1 gene. Results from this test can provide essential information for diagnosis, allowing healthcare providers to develop a tailored management and treatment plan for affected individuals.
The DOLK Gene Glycosylation Disorder Type 1M Genetic Test is a specialized diagnostic assessment designed to identify mutations in the DOLK gene, which can lead to Congenital Disorders of Glycosylation Type 1m (CDG-1m). This condition is a rare genetic disorder that affects the normal process of glycosylation, the attachment of sugars to proteins and lipids, which is crucial for various cellular functions. Mutations in the DOLK gene disrupt this process, leading to a range of symptoms including developmental delay, skin abnormalities, and potential issues with the heart, liver, and muscles.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. Utilizing advanced genetic sequencing technologies, the test examines the DOLK gene for specific mutations known to cause the disorder. This precise approach allows for an accurate diagnosis, which is essential for developing an effective treatment plan and providing genetic counseling.
The cost of the DOLK Gene Glycosylation Disorder Type 1M Genetic Test is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions that can significantly improve the quality of life for affected individuals. Additionally, the test provides vital information for family planning and the assessment of risk for future children.
The B4GALT1 Gene Glycosylation Disorder Type 2D Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the B4GALT1 gene, which are associated with Congenital Disorders of Glycosylation (CDG). CDG Type 2D is a rare genetic condition that affects the body's ability to properly glycosylate proteins and lipids, crucial processes for normal cellular function. This disorder can lead to a wide range of symptoms, including developmental delay, neurological issues, and problems with the digestive system, among others.
The test involves collecting a DNA sample, usually through a blood draw, which is then analyzed in a laboratory setting to detect any genetic anomalies in the B4GALT1 gene. This specific testing is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, known for its state-of-the-art facilities and expertise in genetic diagnostics.
The cost of the B4GALT1 Gene Glycosylation Disorder Type 2D Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the advanced technology and professional expertise required to accurately identify mutations in the B4GALT1 gene. For families and individuals facing the possibility of CDG Type 2D, this test offers a crucial step towards obtaining a definitive diagnosis, which is essential for managing the condition and improving quality of life.
The COG7 Gene Glycosylation Disorder Type 2E Genetic Test is a specialized diagnostic examination conducted to identify mutations in the COG7 gene, which can lead to Congenital Disorders of Glycosylation Type IIe (CDG-IIe). These disorders are a group of inherited conditions that affect the normal process of glycosylation - the addition of sugar chains to proteins and lipids, which is crucial for their proper function. Symptoms of CDG-IIe can vary but often include developmental delay, neurological issues, and abnormalities in liver function.
The test is specifically designed to detect genetic anomalies within the COG7 gene by analyzing the patient's DNA, helping in the accurate diagnosis of the disorder. This is crucial for the management and treatment of the condition, allowing healthcare providers to tailor interventions according to the individual's genetic makeup.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the COG7 Gene Glycosylation Disorder Type 2E Genetic Test is 4400 AED. This investment in health enables patients and their families to gain valuable insights into their genetic conditions, facilitating informed decisions regarding healthcare and potential treatments.
The SLC35A1 gene glycosylation disorder, also known as Congenital Disorder of Glycosylation Type 2F (CDG2F), is a rare genetic condition characterized by defects in the glycosylation process. Glycosylation is a critical biological process where sugars are attached to proteins and lipids, affecting their stability and function. Mutations in the SLC35A1 gene disrupt this process, leading to a wide range of symptoms, including developmental delay, neurological issues, and problems with the digestive system.
To diagnose this condition, a genetic test focusing on the SLC35A1 gene can be conducted. In the United Arab Emirates, DNA Labs UAE offers this specialized test. The test is designed to identify mutations in the SLC35A1 gene that are responsible for the glycosylation disorder Type 2F. The cost of the test is 4400 AED, making it accessible to those who suspect they or their family members might be affected by this rare genetic disorder. Conducting the test can provide crucial information for the diagnosis, management, and treatment of the condition, helping affected individuals and their families to navigate the challenges associated with CDG2F.
The COG1 Gene Glycosylation Disorder Type 2G Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the COG1 gene. These mutations are responsible for a rare condition known as Congenital Disorders of Glycosylation Type 2G (CDG2G), which affects the body's ability to properly glycosylate proteins and lipids, crucial processes for normal cellular function. Symptoms of CDG2G can vary widely among individuals but may include developmental delay, neurological issues, and abnormalities in liver function.
This genetic test involves analyzing the patient's DNA to look for specific mutations in the COG1 gene that are indicative of CDG2G. The test is crucial for confirming a diagnosis, which can then guide treatment plans and help families understand the prognosis and potential genetic counseling needs.
The cost of the COG1 Gene Glycosylation Disorder Type 2G Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the technical process of isolating DNA from the patient's sample, conducting the genetic analysis, and interpreting the results to provide a comprehensive report. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality standards and accuracy in the diagnostic process.
The "COG8 Gene Glycosylation Disorder Type 2H Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COG8 gene, which are responsible for a rare genetic disorder known as Congenital Disorders of Glycosylation Type 2H (CDG2H). This condition is part of a larger group of diseases that affect the glycosylation process, a critical biochemical pathway responsible for adding sugar molecules to proteins and lipids, which is essential for their proper function. Mutations in the COG8 gene disrupt this process, leading to a wide range of symptoms that can include developmental delay, neurological issues, and abnormalities in liver function, among others.
The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw, which is then analyzed in the laboratory to detect any genetic alterations in the COG8 gene. DNA Labs UAE employs state-of-the-art genetic sequencing technologies to ensure accurate and reliable results, which are crucial for the diagnosis and management of this complex disorder. Early detection through genetic testing can significantly benefit affected individuals by enabling timely intervention and personalized treatment plans, ultimately improving the quality of life for those diagnosed with CDG2H.
